Dayton, NJ, United States of America

Hongyu Ren

USPTO Granted Patents = 15 

 

 

Average Co-Inventor Count = 10.1

ph-index = 5

Forward Citations = 71(Granted Patents)


Location History:

  • Dayton, NJ (US) (2010 - 2020)
  • Florence, NJ (US) (2019 - 2021)

Company Filing History:


Years Active: 2010-2021

Loading Chart...
Loading Chart...
Loading Chart...
15 patents (USPTO):

Title: The Innovative Contributions of Hongyu Ren

Introduction

Hongyu Ren is a prominent inventor based in Dayton, NJ (US), known for his significant contributions to the field of cancer research. With a total of 15 patents to his name, Ren has made remarkable strides in developing compounds that target specific proteins involved in cancer progression.

Latest Patents

Among his latest patents are the "Substituted reverse pyrimidine Bmi-1 inhibitors," which describe amine substituted reverse pyrimidine compounds that inhibit the function and reduce the level of B-cell specific Moloney murine leukemia virus integration site 1 (Bmi-1) protein. These compounds and their methods aim to treat cancers mediated by Bmi-1. Another notable patent is the "Substituted pyridine and pyrazine BMI-1 inhibitors," which similarly focuses on amine substituted pyridine and pyrazine compounds that inhibit Bmi-1 function and reduce its levels to combat cancer.

Career Highlights

Hongyu Ren is currently associated with PTC Therapeutics, Inc., where he continues to innovate and develop new therapeutic strategies. His work has been instrumental in advancing the understanding of Bmi-1's role in cancer biology.

Collaborations

Ren has collaborated with notable colleagues, including Richard Gerald Wilde and Gary Mitchell Karp, to further enhance the impact of his research and inventions.

Conclusion

Hongyu Ren's innovative work in developing Bmi-1 inhibitors showcases his dedication to cancer research and his commitment to finding effective treatments. His contributions are paving the way for future advancements in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…